The drug consumption and treatment services site operated by Positive Living Niagara announced it may have to close after a ...

The 2027 Cadillac Vistiq will come standard with Digital Key hardware, but the actual phone-as-key functionality will arrive later via an OTA update.

It's been a good week for CTS Corporation (NYSE:CTS) shareholders, because the company has just released its latest full-year results, and the shares gained 5.0% to US$56.92. The result was positive ...

Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, which are infection and tumor-fighting white blood cells, so that they have a ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...

Cadillac introduced the CTS-V in 2004 after logging about 600 laps around the Nürburgring in a CTS prototype – and the rest is history. The Nürburgring Nordschleife in Germany has long served as a ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

Good morning, and thanks for joining us today. We delivered a quarter of strong double-digit growth in our diversified end markets, with sales up 22% versus the prior year period. Diversified sales ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

CTS Eventim EVD0.00%increase; green up pointing triangle shares dropped after the company said a key profit metric fell in the first half year, although it backed the board’s full-year guidance ...